Literature DB >> 29724576

Dietary intake of energy-dense, nutrient-poor and nutrient-dense food sources in children with cystic fibrosis.

Rosie Sutherland1, Tamarah Katz2, Victoria Liu1, Justine Quintano3, Rebecca Brunner3, Chai Wei Tong1, Clare E Collins4, Chee Y Ooi5.   

Abstract

BACKGROUND: Prescription of a high-energy, high-fat diet is a mainstay of nutrition management in cystic fibrosis (CF). However, families may be relying on energy-dense, nutrient-poor (EDNP) foods rather than nutrient-dense (ND) foods to meet dietary targets. We aimed to evaluate the relative contribution of EDNP and ND foods to the usual diets of children with CF and identify sociodemographic factors associated with higher EDNP intakes.
METHODS: This is a cross-sectional comparison of children with CF aged 2-18 years and age- and gender-matched controls. Dietary intake was assessed using the Australian Child and Adolescent Eating Survey (ACAES) food frequency questionnaire.
RESULTS: Children with CF (n = 80: 37 males; mean age 9.3 years) consumed significantly more EDNP foods than controls (mean age 9.8 years) in terms of both total energy (median [IQR]: 1301 kcal/day (843-1860) vs. 686 kcal/day (480-1032); p < 0.0001), and as a proportion of energy intake (median [IQR]: 44% (34-51) vs. 31% (24-43); p < 0.0001). Although children with CF met their estimated energy requirements (median [IQR]: 158% (124-187) vs. 112% (90-137); p < 0.0001) and their diets were high in fat (median [IQR]: 38% (35-41) vs. 34% (32-36); p < 0.0001), this was largely attributable to EDNP foods. High EDNP intakes (≥10 serves/day) were associated with socioeconomic disadvantage (p = 0.01) and rural residential location (p = 0.03). DISCUSSION: The energy- and fat-dense CF diet is primarily achieved by overconsumption of EDNP foods, rather than ND sources. This dietary pattern may not be optimal for the future health of children with CF, who are now expected to survive well into adulthood.
Copyright © 2018 European Cystic Fibrosis Society. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; Diet; FFQ; Nutrition; Paediatric

Mesh:

Substances:

Year:  2018        PMID: 29724576     DOI: 10.1016/j.jcf.2018.03.011

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  20 in total

1.  Probiotics for people with cystic fibrosis.

Authors:  Michael J Coffey; Millie Garg; Nusrat Homaira; Adam Jaffe; Chee Y Ooi
Journal:  Cochrane Database Syst Rev       Date:  2020-01-22

Review 2.  The demographics of adverse outcomes in cystic fibrosis.

Authors:  Meghan E McGarry; Wadsworth A Williams; Susanna A McColley
Journal:  Pediatr Pulmonol       Date:  2019-11

3.  Visceral adipose tissue is associated with poor diet quality and higher fasting glucose in adults with cystic fibrosis.

Authors:  Moriah P Bellissimo; Ivana Zhang; Elizabeth A Ivie; Phong H Tran; Vin Tangpricha; William R Hunt; Arlene A Stecenko; Thomas R Ziegler; Jessica A Alvarez
Journal:  J Cyst Fibros       Date:  2019-01-18       Impact factor: 5.482

Review 4.  Scoping review of the dietary intake of children with chronic kidney disease.

Authors:  Erin Melhuish; Rachel Lindeback; Kelly Lambert
Journal:  Pediatr Nephrol       Date:  2022-03-11       Impact factor: 3.651

5.  Academy of Nutrition and Dietetics: 2020 Cystic Fibrosis Evidence Analysis Center Evidence-Based Nutrition Practice Guideline.

Authors:  Catherine M McDonald; Jessica A Alvarez; Julianna Bailey; Ellen K Bowser; Kristen Farnham; Mark Mangus; Laura Padula; Kathleen Porco; Mary Rozga
Journal:  J Acad Nutr Diet       Date:  2020-06-19       Impact factor: 5.234

6.  The intestinal virome in children with cystic fibrosis differs from healthy controls.

Authors:  Michael J Coffey; Ivan Low; Sacha Stelzer-Braid; Bernd Wemheuer; Millie Garg; Torsten Thomas; Adam Jaffe; William D Rawlinson; Chee Y Ooi
Journal:  PLoS One       Date:  2020-05-22       Impact factor: 3.240

7.  Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation.

Authors:  Chee Y Ooi; Saad A Syed; Laura Rossi; Millie Garg; Bronwen Needham; Julie Avolio; Kelsey Young; Michael G Surette; Tanja Gonska
Journal:  Sci Rep       Date:  2018-12-13       Impact factor: 4.379

8.  Change in Nutrient and Dietary Intake in European Children with Cystic Fibrosis after a 6-Month Intervention with a Self-Management mHealth Tool.

Authors:  Joaquim Calvo-Lerma; Mieke Boon; Jessie Hulst; Carla Colombo; Inês Asseiceira; María Garriga; Etna Masip; Ine Claes; Anna Bulfamante; Hettie M Janssens; Maria Roca; Saioa Vicente; Victoria Fornés; Laura Zazzeron; Bo van Schijndel; Sandra Woodcock; Luisa Pereira; Kris de Boeck; Carmen Ribes-Koninckx
Journal:  Nutrients       Date:  2021-05-26       Impact factor: 5.717

9.  Changes in fecal microbiota with CFTR modulator therapy: A pilot study.

Authors:  C E Pope; A T Vo; H S Hayden; E J Weiss; S Durfey; S McNamara; A Ratjen; B Grogan; S Carter; L Nay; M R Parsek; P K Singh; E F McKone; M L Aitken; M R Rosenfeld; L R Hoffman
Journal:  J Cyst Fibros       Date:  2020-12-31       Impact factor: 5.527

10.  Evaluating the Alimentary and Respiratory Tracts in Health and disease (EARTH) research programme: a protocol for prospective, longitudinal, controlled, observational studies in children with chronic disease at an Australian tertiary paediatric hospital.

Authors:  Michael J Coffey; Isabelle R McKay; Michael Doumit; Sandra Chuang; Susan Adams; Sacha Stelzer-Braid; Shafagh A Waters; Nadine A Kasparian; Torsten Thomas; Adam Jaffe; Tamarah Katz; Chee Y Ooi
Journal:  BMJ Open       Date:  2020-04-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.